INVO Bioscience, Inc. (60) | Business Operations (12)
Browse by Subcategory
Recent Contracts
-
Exclusive Distribution Agreement
(Filed With SEC on May 16, 2022)
-
Termination Notice to Paradigm Opportunities Fund, LP dated March 30, 2022
(Filed With SEC on March 31, 2022)
-
INVOcell Supply Agreement
(Filed With SEC on December 2, 2021)
-
Management Services Agreement
(Filed With SEC on June 30, 2021)
-
Settlement Agreement and General Release dated November 11, 2019
(Filed With SEC on November 14, 2019)
-
Termination Notice to Medesole Healthcare and Trading Private Limited dated March 29, 2022
(Filed With SEC on March 31, 2022)
-
Termination Notice
(Filed With SEC on November 8, 2021)
-
INVOcell Supply Agreement
(Filed With SEC on June 30, 2021)
-
Amendment No. 1 to Distribution Agreement
(Filed With SEC on March 8, 2021)
-
Distribution Agreement
(Filed With SEC on December 8, 2020)
-
Distribution Agreement
(Filed With SEC on November 25, 2020)
-
Supply Agreement between the INVO Bioscience, Inc and Ferring International Center S.A
(Filed With SEC on April 16, 2019)